Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 321

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 321
---
 and regulations that may affect our ability to conduct business, include, without limitation:

| • |     | FDA, Department of Justice, and other government authority prohibitions against the advertisement, promotion and 
 labeling of our products for off-label uses, or uses outside the specific indications approved by the FDA;       |

| • |     | the federal Anti-Kickback Statute, which broadly prohibits, among other things, any person from knowingly and                                                                                                                                          
 willfully offering, soliciting, receiving or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment 
 may be made under federal healthcare programs, such as Medicare or Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation;                                  |

| • |     | the federal False Claims Act, which prohibits, among other things, individuals or entities from knowingly                                                                                                                                                                                                                                                                          
 presenting, or causing to be presented, false claims, or knowingly using false statements, to obtain payment from the federal government. These laws have been interpreted to apply to arrangements between manufacturers, on the one hand, and                                                                                                                                    
 prescribers, purchasers, and other healthcare-related professionals on the other. They can apply to manufacturers who provide inaccurate information on coverage, coding, and reimbursement of their products to persons who bill third-party payers. In                                                                                                                           
 addition, manufacturers have been prosecuted or faced civil and criminal liability under these laws for a variety of alleged promotional and marketing activities, including violations of the federal Anti-Kickback Statute and engaging in off-label promotion that caused claims to be submitted for non-covered off-label uses. Private individuals can bring False Claims Act 
 “qui tam” actions, on behalf of the government and such individuals, commonly known as “whistleblowers,” may share in amounts paid by the entity to the government in fines or settlement;                                                                                                                                                                                         |

| • |     | the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), as amended, which among                                                                                                                                                  
 other things, also created criminal liability for knowingly and willfully falsifying or concealing a material fact or making a materially false statement in connection with the delivery of or payment for healthcare benefits, items or services. 
 Similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in